US Health Regulator has given its approval to Modafinil and Solifenacin Succinate tablets. These will be manufactured at Zydus Cadila, Pharma SEZ, Ahmedabad facility. USFDA has also given its final approval to the company to market Modafinil tablets USP in the strengths of 100 mg and 200 mg. The drug will help in improving wakefulness in adults with excessive sleepiness associated with narcolepsy, obstructive sleep apnoea or shift work disorder. The company also received tentative approval for Solifenacin Succinate tablets in strengths of 5 mg and 10 mg which will help in the treatment of overactive bladder. Since the commencement of the company, it has more than 150 approvals and about 300 Abbreviated New Drug Applications (ANDAs).